Auf dieser Seite
CNMD CONMED Corporation Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 6, 2026 10-K/10-Q Jul 29, 2026
$44,48
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$31,4452-Wochen-Tief
$53,6652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.39B
P/E (TTM)
24.0
EPS (TTM)
$1.85
Umsatz (TTM)
$1.37B
Ihre Abzeichen
52W-Spanne
$31–$54
Analystenbewertung
HOLD
Kursziel
$46
P/E
24.0
ROE
5.5%
Nettogewinnmarge
4.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CNMD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$44.48
Marktkapitalisierung (MRQ)
$1.39B
P/E (TTM)
24.0
EPS (TTM)
$1.85
Umsatz (TTM)
$1.37B
Dividendenrendite
1.8%
ROE (TTM)
5.5%
52W-Spanne
$31–$54
CNMD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 10. September 2001 | 3-for-2 | Vorwärts |
| 1. Dezember 1995 | 3-for-2 | Vorwärts |
| 28. Dezember 1994 | 3-for-2 | Vorwärts |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$1.37B2016-12-31 → 2025-12-31
EPS$1.512016-12-31 → 2025-12-31
Freier Cashflow$151M2016-12-31 → 2025-12-31
Nettogewinnmarge4.1%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CNMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 24.05-Jahres-Durchschnitt ≈27.3 | ≈27.3 | 33.6 | Unterbewertet | |
| P/S (TTM) | 1.05-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 2.4 | Unterbewertet | |
| K/B (MRQ) | 1.35-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 4.4 | Unterbewertet | |
| Kurs / FCF (TTM) | 10.45-Jahres-Durchschnitt ≈68.0 | ≈68.0 | · | · | |
| Kurs / Cashflow (TTM) | 9.25-Jahres-Durchschnitt ≈34.1 | ≈34.1 | 26.2 | Unterbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 2.9 | · | · | · | |
| PEG Ratio (PEG-Ratio) | ≈0.7 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CNMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 55.8%5-Jahres-Durchschnitt ≈55.2% | ≈55.2% | 60.8% | Im Einklang | |
| Betriebsgewinnmarge (TTM) | 8.0%5-Jahres-Durchschnitt ≈10.0% | ≈10.0% | 10.4% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | 7.5%5-Jahres-Durchschnitt ≈10.0% | ≈10.0% | 10.6% | Im Einklang | |
| Vorgewinnmarge (TTM) | 6.1%5-Jahres-Durchschnitt ≈4.9% | ≈4.9% | 9.1% | Im Einklang | |
| Nettogewinnmarge (TTM) | 4.1%5-Jahres-Durchschnitt ≈3.4% | ≈3.4% | 6.7% | Im Einklang | |
| ROA (TTM) | 2.4%5-Jahres-Durchschnitt ≈2.0% | ≈2.0% | 1.2% | Spitzenklasse | |
| ROE (TTM) | 5.5%5-Jahres-Durchschnitt ≈4.7% | ≈4.7% | 2.2% | Spitzenklasse | |
| ROIC | 6.6%5-Jahres-Durchschnitt ≈11.5% | ≈11.5% | 3.4% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CNMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.55-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 3.2 | Geringe Liquidität | |
| Quick Ratio | 0.85-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 1.6 | Geringe Liquidität | |
| Interest Coverage (Zinsdeckungsgrad) | 3.35-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 3.3 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CNMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 5.2%5-Jahres-Durchschnitt ≈10.0% | ≈10.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 9.6%5-Jahres-Durchschnitt ≈10.5% | ≈10.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 9.8% | · | · | · | |
| EPS YoY (EPS VjV) | -64.5%5-Jahres-Durchschnitt ≈183.4% | ≈183.4% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -64.5%5-Jahres-Durchschnitt ≈199.4% | ≈199.4% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 29.9% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 36.4% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 28.4% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 37.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CNMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.6 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 1.85-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 1.8 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 5.75-Jahres-Durchschnitt ≈5.6 | ≈5.6 | 6.9 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$352.5K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite1.8%
Ausschüttungsquote52.6%
Annualisierte Auszahlung≈$0.80
5J Div CAGR≈0.00%
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Sep 15, 2025 | $0,20 | USD | ≈1.5% |
| Jun 13, 2025 | $0,20 | USD | ≈1.5% |
| Mär 14, 2025 | $0,20 | USD | ≈1.4% |
| Dez 20, 2024 | $0,20 | USD | ≈1.2% |
| Sep 16, 2024 | $0,20 | USD | ≈1.1% |
| Jun 14, 2024 | $0,20 | USD | ≈1.1% |
| Mär 14, 2024 | $0,20 | USD | ≈1.0% |
| Dez 15, 2023 | $0,20 | USD | ≈0.71% |
| Sep 14, 2023 | $0,20 | USD | ≈0.74% |
| Jun 14, 2023 | $0,20 | USD | ≈0.59% |
| Mär 14, 2023 | $0,20 | USD | ≈0.86% |
| Dez 15, 2022 | $0,20 | USD | ≈0.93% |
| Sep 14, 2022 | $0,20 | USD | ≈0.86% |
| Jun 14, 2022 | $0,20 | USD | ≈0.86% |
| Mär 14, 2022 | $0,20 | USD | ≈0.59% |
| Dez 14, 2021 | $0,20 | USD | ≈0.60% |
| Sep 14, 2021 | $0,20 | USD | ≈0.64% |
| Jun 14, 2021 | $0,20 | USD | ≈0.58% |
| Mär 12, 2021 | $0,20 | USD | ≈0.64% |
| Dez 14, 2020 | $0,20 | USD | ≈0.76% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.4%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 28, 2026 | $1.38 | $1.13 | 21.8% |
| 31. März 2026 | $0.89 | $0.84 | 6.5% | |
| 31. Dezember 2025 | $1.43 | $1.35 | 5.9% | |
| 30. September 2025 | $1.08 | $1.07 | 0.66% | |
| 30. Juni 2025 | $1.15 | $1.15 | 0.37% | |
| 31. März 2025 | $0.95 | $0.83 | 14.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862M | $955M | $860M | $796M | $764M | $719M | $740M | |
| Cost of Revenue | $624M | $574M | $568M | $474M | $443M | $402M | $430M | $391M | $365M | $355M | $337M | $336M | |
| Gross Profit | $750M | $733M | $676M | $571M | $568M | $460M | $525M | $469M | $431M | $408M | $382M | $404M | |
| R&D Expense | $56M | $54M | $53M | $47M | $44M | $40M | $45M | $42M | $32M | $32M | $27M | $28M | |
| SG&A Expense | $592M | $478M | $503M | $454M | $415M | $374M | $400M | $356M | $352M | $338M | $303M | $323M | |
| Operating Expenses | $648M | $533M | $556M | $501M | $458M | $414M | $446M | $398M | $384M | $371M | $331M | $351M | |
| Operating Income | $103M | $200M | $121M | $70M | $110M | $46M | $79M | $71M | $47M | $38M | $51M | $53M | |
| Interest Expense | $31M | $37M | $40M | $29M | $35M | $44M | $43M | $21M | $18M | $15M | $6M | $6M | |
| Pretax Income | $71M | $163M | $81M | $-71M | $73M | $2M | $31M | $51M | $29M | $19M | $45M | $47M | |
| Income Tax | $24M | $31M | $16M | $10M | $11M | $-8M | $3M | $10M | $-27M | $5M | $15M | $14M | |
| Net Income | $47M | $132M | $64M | $-81M | $63M | $10M | $29M | $41M | $55M | $15M | $30M | $32M | |
| EPS (Basic) | $1.52 | $4.29 | $2.10 | $-2.68 | $2.14 | $0.33 | $1.01 | $1.45 | $1.99 | $0.53 | $1.10 | $1.17 | |
| EPS (Diluted) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 | $1.09 | $1.16 | |
| Shares (Basic) | 31,036,000 | 30,846,000 | 30,668,000 | 30,040,000 | 29,162,000 | 28,581,000 | 28,325,000 | 28,118,000 | 27,939,000 | 27,804,000 | 27,653,000 | 27,401,000 | |
| Shares (Diluted) | 31,149,000 | 31,150,000 | 31,548,000 | 30,040,000 | 32,216,000 | 29,464,000 | 29,495,000 | 28,890,000 | 28,171,000 | 27,964,000 | 27,858,000 | 27,769,000 | |
| EBITDA | $103M | $200M | $121M | $70M | $110M | $46M | $79M | $71M | $47M | $38M | $51M | $53M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $26M | $18M | $33M | $27M | $73M | $66M | |
| Receivables | $248M | $238M | $242M | $191M | $184M | $177M | $189M | $182M | $167M | $148M | $134M | $129M | |
| Inventory | $356M | $347M | $318M | $332M | $232M | $195M | $165M | $155M | $141M | $136M | $133M | $148M | |
| Prepaid Expense | $29M | $31M | $31M | $29M | $24M | $17M | $18M | $21M | $16M | $19M | $20M | $22M | |
| Current Assets | $673M | $640M | $616M | $581M | $460M | $417M | $397M | $374M | $357M | $331M | $360M | $381M | |
| PP&E (Net) | $113M | $116M | $121M | $116M | $109M | $111M | $119M | $113M | $116M | $122M | $125M | $133M | |
| PP&E (Gross) | $430M | $421M | $413M | $393M | $373M | $357M | $347M | $332M | $323M | $308M | $293M | $298M | |
| Accum. Depreciation | $317M | $305M | $292M | $278M | $264M | $246M | $228M | $219M | $207M | $186M | $168M | $164M | |
| Goodwill | $807M | $805M | $807M | $815M | $618M | $618M | $618M | $400M | $402M | $398M | $261M | $256M | |
| Intangibles | $582M | $618M | $649M | $682M | $471M | $502M | $533M | $413M | $415M | $420M | $308M | $316M | |
| Other Non-current Assets | $150M | $116M | $96M | $94M | $99M | $104M | $108M | $68M | $68M | · | · | · | |
| Total Assets | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B | $1.75B | $1.78B | $1.37B | $1.36B | $1.33B | $1.10B | $1.10B | |
| Accounts Payable | $94M | $102M | $88M | $73M | $58M | $53M | $56M | $53M | $42M | $42M | $35M | $24M | |
| Current Liabilities | $315M | $278M | $311M | $297M | $197M | $190M | $188M | $161M | $150M | $114M | $120M | $116M | |
| Capital Leases | $44M | $33M | $10M | $12M | $13M | $15M | $17M | · | · | · | · | · | |
| Deferred Tax | $80M | $74M | $61M | $67M | $69M | $58M | $74M | $81M | $78M | $119M | $103M | $112M | |
| Other Non-current Liabilities | $64M | $86M | $121M | $204M | $43M | $59M | $47M | $26M | $27M | $27M | $24M | $49M | |
| Total Liabilities | $1.29B | $1.34B | $1.47B | $1.55B | $981M | $1.04B | $1.06B | $707M | $727M | $748M | $517M | $517M | |
| Long-term Debt | · | · | · | · | · | · | · | $457M | $486M | $498M | $271M | $241M | |
| Total Debt | · | · | · | · | · | · | · | $457M | $486M | $498M | $271M | $241M | |
| Common Stock | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | |
| Paid-in Capital | $503M | $477M | $447M | $413M | $397M | $383M | $379M | $342M | $334M | $329M | $325M | $320M | |
| Retained Earnings | $589M | $560M | $453M | $413M | $497M | $457M | $471M | $465M | $440M | $407M | $415M | $406M | |
| Treasury Stock | $13M | $16M | $15M | $23M | $54M | $68M | $81M | $89M | $94M | $97M | $101M | $105M | |
| AOCI | $-46M | $-59M | $-50M | $-58M | $-54M | $-64M | $-59M | $-56M | $-49M | $-59M | $-54M | $-40M | |
| Stockholders' Equity | $1.03B | $963M | $834M | $746M | $785M | $709M | $710M | $662M | $631M | $581M | $585M | $581M | |
| Liabilities + Equity | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B | $1.75B | $1.78B | $1.37B | $1.36B | $1.33B | $1.10B | $1.10B | |
| Shares Outstanding | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $26M | $24M | $22M | $16M | $13M | $12M | $10M | $8M | $8M | $7M | $9M | |
| Deferred Tax | $4M | $12M | $700.0K | $-6M | $3M | $-14M | $-6M | $2M | $-40M | $-3M | $2M | $-284.0K | |
| Amort. of Intangibles | $35M | $35M | $35M | $34M | $33M | $34M | $32M | $23M | $21M | $20M | $13M | $13M | |
| Restructuring | · | · | · | · | · | · | · | · | $4M | $10M | $22M | $22M | |
| Operating Cash Flow | $171M | $167M | $125M | $33M | $112M | $65M | $95M | $75M | $66M | $40M | $51M | $65M | |
| CapEx | $20M | $13M | $19M | $22M | $15M | $13M | $20M | $17M | $13M | $15M | $15M | $15M | |
| Investing Cash Flow | $-21M | $-13M | $-20M | $-250M | $-15M | $-14M | $-388M | $-17M | $-29M | $-266M | $-24M | $-21M | |
| Debt Issued | · | · | · | · | · | · | $265M | $0 | $0 | $175M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $111M | $-13M | $-9M | $166M | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $0 | $0 | $17M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | $0 | $-17M | |
| Dividends Paid | $25M | $25M | $25M | $24M | $23M | $23M | $23M | $22M | $22M | $22M | $22M | $22M | |
| Financing Cash Flow | $-136M | $-151M | $-110M | $225M | $-102M | $-52M | $301M | $-72M | $-35M | $183M | $-13M | $-26M | |
| Net Change in Cash | $16M | $163.0K | $-5M | $8M | $-7M | $2M | $8M | $-15M | $5M | $-45M | $6M | $12M | |
| Taxes Paid | $21M | $17M | $19M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $151M | $154M | $106M | $12M | $97M | $52M | $75M | $58M | $53M | $23M | $33M | $50M | |
| Levered FCF | $130M | $124M | $75M | $-21M | $67M | $-210M | $36M | $42M | $18M | $12M | $29M | $46M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% | 53.4% | 54.9% | 54.6% | 54.1% | 53.5% | 53.1% | 54.6% | |
| Operating Margin | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% | 7.1% | 7.1% | |
| Net Margin | 3.4% | 10.1% | 5.2% | -7.7% | 6.2% | 1.1% | 3.0% | 4.8% | 7.0% | 1.9% | 4.2% | 4.3% | |
| Pretax Margin | 5.2% | 12.5% | 6.5% | -6.8% | 7.2% | 0.19% | 3.3% | 5.9% | 3.6% | 2.5% | 6.3% | 6.3% | |
| EBITDA Margin | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% | 7.1% | 7.1% | |
| ROA | 2.0% | 5.8% | 2.8% | -4.0% | 3.6% | 0.54% | 1.8% | 3.0% | 4.1% | 1.2% | 2.8% | 2.9% | |
| ROE | 4.6% | 14.0% | 7.9% | -11.0% | 8.1% | 1.4% | 4.1% | 6.2% | 9.2% | 2.5% | 5.2% | 5.4% | |
| ROIC | 6.6% | 16.9% | 11.5% | 10.7% | 11.9% | 38.5% | 10.2% | 5.1% | 8.1% | 2.6% | 4.0% | 4.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.3 | 2.0 | 2.0 | 2.3 | 2.2 | 2.1 | 2.3 | 2.4 | 2.9 | 3.4 | 3.3 | |
| Quick Ratio | 0.8 | 0.9 | 0.8 | 0.6 | 0.9 | 0.9 | 1.1 | 1.2 | 1.3 | 1.5 | 1.7 | 1.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.7 | 0.8 | 0.9 | 0.5 | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.7 | 0.7 | 0.8 | 0.5 | 0.4 | |
| Interest Coverage | 3.3 | 5.4 | 3.0 | 2.4 | 3.1 | 1.0 | 1.9 | 3.5 | 2.6 | 2.5 | 8.5 | 8.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.8 | 1.7 | 1.7 | 1.7 | 2.1 | 2.2 | 2.7 | 2.6 | 2.6 | 2.6 | 2.1 | 2.3 | |
| Receivables Turnover | 5.7 | 5.4 | 5.7 | 5.6 | 5.6 | 4.7 | 5.2 | 4.9 | 5.1 | 5.4 | 5.5 | 5.5 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.01 | $30.76 | $26.65 | $23.82 | $25.09 | $22.65 | $22.70 | $21.16 | $20.17 | $18.55 | $18.69 | $18.57 | |
| Revenue / Share | $44.13 | $41.96 | $39.46 | $34.80 | $31.37 | $29.27 | $32.38 | $29.76 | $28.27 | $27.30 | $25.82 | $26.65 | |
| Cash Flow / Share | $5.48 | $5.36 | $3.97 | $1.11 | $3.47 | $2.19 | $3.23 | $2.59 | $2.33 | $1.37 | $1.73 | $2.35 | |
| Cash / Share | · | · | · | · | · | · | $0.83 | $0.56 | $1.04 | $0.88 | $2.32 | $2.12 | |
| Dividend / Share | $0.60 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | |
| EPS (TTM) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 | $1.09 | $1.16 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.2% | 5.0% | 19.1% | 3.5% | 17.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.6% | 8.9% | 13.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -64.5% | 108.3% | · | · | 506.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 29.9% | 85.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 36.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -64.5% | 105.4% | · | · | 557.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 28.4% | 89.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 37.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 1.6% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862M | $955M | $860M | $796M | $764M | $719M | $740M | |
| Net Income TTM | $47M | $132M | $64M | $-81M | $63M | $10M | $29M | $41M | $55M | $15M | $30M | $32M | |
| Market Cap | $1.27B | $2.14B | $3.43B | $2.77B | $4.44B | $3.51B | $3.50B | $2.01B | $1.60B | $1.38B | $1.38B | $1.41B | |
| Enterprise Value | · | · | · | · | · | · | · | $2.45B | $2.05B | $1.85B | $1.58B | $1.58B | |
| P/E | 26.9 | 16.1 | 53.7 | -33.1 | 73.1 | 350.0 | 115.3 | 45.5 | 25.9 | 84.9 | 40.4 | 38.8 | |
| P/S | 0.9 | 1.6 | 2.8 | 2.7 | 4.4 | 4.1 | 3.7 | 2.3 | 2.0 | 1.8 | 1.9 | 1.9 | |
| P/B | 1.2 | 2.2 | 4.1 | 3.7 | 5.6 | 4.9 | 4.9 | 3.0 | 2.5 | 2.4 | 2.4 | 2.4 | |
| P / Cash Flow | 7.4 | 12.8 | 27.3 | 83.2 | 39.7 | 54.3 | 36.8 | 26.9 | 24.3 | 36.2 | 28.7 | 21.6 | |
| P / FCF | 8.4 | 13.9 | 32.2 | 239.6 | 45.8 | 68.0 | 46.6 | 34.5 | 30.3 | 58.9 | 41.7 | 28.3 | |
| EV / EBITDA | · | · | · | · | · | · | · | 34.3 | 43.7 | 49.2 | 30.8 | 30.0 | |
| EV / FCF | · | · | · | · | · | · | · | 42.1 | 38.9 | 79.0 | 47.7 | 31.8 | |
| EV / Revenue | · | · | · | · | · | · | · | 2.8 | 2.6 | 2.4 | 2.2 | 2.1 | |
| Dividend Yield | 1.9% | 1.1% | 0.71% | 0.86% | 0.52% | 0.65% | 0.65% | 1.1% | 1.4% | 1.6% | 1.6% | 1.6% | |
| Earnings Yield | 3.7% | 6.2% | 1.9% | -3.0% | 1.4% | 0.29% | 0.87% | 2.2% | 3.9% | 1.2% | 2.5% | 2.6% | |
| Payout Ratio | 52.6% | 18.6% | 38.0% | -29.7% | 37.2% | 239.8% | 79.0% | 54.9% | 40.2% | 151.5% | 72.5% | 68.2% | |
| Annual Payout | $25M | $25M | $25M | $24M | $23M | $23M | $23M | $22M | $22M | $22M | $22M | $22M |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $343M | $317M | $373M | $338M | $342M | $321M | $346M | $317M | $332M | $312M | $327M | $305M | $318M | $295M | $251M | $275M | |
| Cost of Revenue | $146M | $134M | $155M | $172M | $154M | $144M | $148M | $138M | $148M | $140M | $145M | $137M | $147M | $140M | $119M | $123M | |
| Gross Profit | $197M | $183M | $218M | $166M | $188M | $178M | $198M | $179M | $184M | $172M | $182M | $168M | $171M | $155M | $132M | $152M | |
| R&D Expense | $16M | $16M | $15M | $14M | $14M | $13M | $13M | $14M | $14M | $14M | $14M | $12M | $14M | $13M | $12M | $13M | |
| SG&A Expense | $146M | $142M | $167M | $140M | $136M | $149M | $133M | $100M | $123M | $123M | $118M | $125M | $130M | $130M | $121M | $115M | |
| Operating Expenses | $161M | $158M | $182M | $154M | $150M | $162M | $146M | $113M | $137M | $137M | $132M | $138M | $143M | $143M | $133M | $127M | |
| Operating Income | $36M | $25M | $37M | $12M | $38M | $16M | $52M | $66M | $47M | $35M | $50M | $30M | $27M | $13M | $-1M | $24M | |
| Interest Expense | $8M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | |
| Other Non-op | $3M | · | · | · | $-418.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $31M | $18M | $29M | $4M | $30M | $8M | $44M | $56M | $38M | $25M | $41M | $20M | $17M | $2M | $-11M | $16M | |
| Income Tax | $8M | $5M | $13M | $1M | $8M | $2M | $10M | $7M | $8M | $6M | $8M | $4M | $4M | $625.0K | $-37M | $-30M | |
| Net Income | $23M | $14M | $17M | $3M | $21M | $6M | $34M | $49M | $30M | $20M | $33M | $16M | $14M | $2M | $27M | $46M | |
| EPS (Basic) | $0.77 | $0.45 | $0.55 | $0.09 | $0.69 | $0.19 | $1.09 | $1.59 | $0.97 | $0.64 | $1.07 | $0.52 | $0.45 | $0.06 | $0.95 | $1.51 | |
| EPS (Diluted) | $0.77 | $0.45 | $0.54 | $0.09 | $0.69 | $0.19 | $1.09 | $1.57 | $0.96 | $0.63 | $1.05 | $0.50 | $0.43 | $0.06 | $1.02 | $1.48 | |
| Shares (Basic) | 30,069,000 | 30,588,000 | · | 30,955,000 | 30,949,000 | 30,973,000 | · | 30,856,000 | 30,813,000 | 30,780,000 | · | 30,741,000 | 30,662,000 | 30,511,000 | · | 30,473,000 | |
| Shares (Diluted) | 30,117,000 | 30,621,000 | · | 31,050,000 | 31,054,000 | 31,151,000 | · | 31,112,000 | 31,106,000 | 31,272,000 | · | 31,689,000 | 31,795,000 | 31,204,000 | · | 31,103,000 | |
| EBITDA | $36M | $25M | · | $12M | $38M | $16M | · | $66M | $47M | $35M | · | $30M | $27M | $13M | · | $24M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $240M | $229M | $248M | $225M | $234M | $221M | $238M | $231M | $239M | $241M | · | $230M | $229M | $213M | · | $197M | |
| Inventory | $360M | $366M | $356M | $364M | $362M | $355M | $347M | $343M | $322M | $322M | · | $326M | $327M | $335M | · | $305M | |
| Prepaid Expense | $38M | $41M | $29M | $34M | $27M | $28M | $31M | $29M | $33M | $38M | · | $39M | $31M | $35M | · | $39M | |
| Current Assets | $676M | $671M | $673M | $662M | $658M | $639M | $640M | $641M | $624M | $636M | · | $626M | $616M | $610M | · | $574M | |
| PP&E (Net) | $110M | $112M | $113M | $112M | $117M | $116M | $116M | $117M | $117M | $118M | · | $120M | $117M | $115M | · | $114M | |
| PP&E (Gross) | · | · | $430M | · | · | · | $421M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $317M | · | · | · | $305M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $797M | $807M | $807M | $807M | $807M | $806M | $805M | $807M | $806M | $806M | $807M | $815M | $816M | $815M | $815M | $814M | |
| Intangibles | $564M | $574M | $582M | $593M | $602M | $610M | $618M | $626M | $633M | $641M | · | $657M | $666M | $674M | · | $689M | |
| Other Non-current Assets | $153M | $152M | $137M | $148M | $145M | $127M | $116M | $125M | $105M | $108M | · | $107M | $109M | $106M | · | $100M | |
| Total Assets | $2.30B | $2.31B | $2.33B | $2.32B | $2.33B | $2.30B | $2.31B | $2.32B | $2.29B | $2.31B | · | $2.33B | $2.32B | $2.32B | · | $2.29B | |
| Accounts Payable | $101M | $105M | $94M | $107M | $101M | $96M | $102M | $105M | $101M | $102M | · | $82M | $79M | $77M | · | $74M | |
| Current Liabilities | $455M | $293M | $315M | $315M | $295M | $283M | $278M | $282M | $266M | $291M | · | $376M | $353M | $321M | · | $209M | |
| Capital Leases | · | · | $44M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $85M | $81M | $80M | $75M | $70M | $70M | $74M | $66M | $65M | $64M | · | $67M | $66M | $66M | · | $113M | |
| Other Non-current Liabilities | $62M | $63M | $64M | $72M | $80M | $76M | $86M | $95M | $107M | $109M | · | $144M | $152M | $186M | · | $218M | |
| Total Liabilities | $1.26B | $1.30B | $1.29B | $1.31B | $1.33B | $1.32B | $1.34B | $1.38B | $1.40B | $1.45B | · | $1.53B | $1.54B | $1.57B | · | $1.58B | |
| Common Stock | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | · | $313.0K | $313.0K | $313.0K | · | $313.0K | |
| Paid-in Capital | $513M | $508M | $503M | $499M | $494M | $489M | $477M | $471M | $465M | $458M | · | $440M | $433M | $420M | · | $407M | |
| Retained Earnings | $626M | $603M | $589M | $572M | $575M | $560M | $560M | $533M | $490M | $466M | · | $426M | $416M | $408M | · | $392M | |
| Treasury Stock | $55M | $49M | $13M | $14M | $14M | $15M | $16M | $16M | $19M | $20M | · | $15M | $16M | $21M | · | $23M | |
| AOCI | $-43M | $-45M | $-46M | $-49M | $-53M | $-57M | $-59M | $-55M | $-54M | $-50M | · | $-54M | $-53M | $-55M | · | $-60M | |
| Stockholders' Equity | $1.04B | $1.02B | $1.03B | $1.01B | $1.00B | $978M | $963M | $933M | $882M | $855M | $834M | $796M | $780M | $752M | $746M | $716M | |
| Liabilities + Equity | $2.30B | $2.31B | $2.33B | $2.32B | $2.33B | $2.30B | $2.31B | $2.32B | $2.29B | $2.31B | · | $2.33B | $2.32B | $2.32B | · | $2.29B | |
| Shares Outstanding | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $5M | $5M | $5M | $14M | $6M | $6M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Deferred Tax | $2M | $2M | $812.0K | $4M | $2M | $-3M | $7M | $3M | $1M | $2M | $2M | $-284.0K | $533.0K | $-1M | $-44M | $-32M | |
| Amort. of Intangibles | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Operating Cash Flow | $37M | $13M | $46M | $54M | $29M | $42M | $43M | $51M | $43M | $29M | $56M | $46M | $27M | $-4M | $-12M | $26M | |
| CapEx | $3M | $3M | $5M | $5M | $6M | $4M | $4M | $3M | $4M | $2M | $5M | $5M | $5M | $4M | $6M | $7M | |
| Investing Cash Flow | $12M | $4M | $-7M | $-5M | $-6M | $-3M | $-4M | $-3M | $-4M | $-2M | $-5M | $-5M | $-6M | $-4M | $-6M | $-91M | |
| Stock Repurchased | $6M | $37M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-37M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $0 | $0 | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-46M | $-23M | $-37M | $-44M | $-27M | $-28M | $-51M | $-39M | $-44M | $-17M | $-59M | $-37M | $-20M | $5M | $12M | $47M | |
| Net Change in Cash | $2M | $-6M | $2M | $5M | $-2M | $11M | $-14M | $10M | $-5M | $10M | $-6M | $3M | $1M | $-2M | $-4M | $-20M | |
| Free Cash Flow | · | $11M | · | · | · | $38M | · | · | · | $27M | · | · | · | $-8M | · | · | |
| Levered FCF | · | $5M | · | · | · | $31M | · | · | · | $20M | · | · | · | $-16M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.5% | 57.9% | · | 49.2% | 55.0% | 55.3% | · | 56.5% | 55.3% | 55.1% | · | 55.2% | 53.7% | 52.6% | · | 55.1% | |
| Operating Margin | 10.6% | 8.0% | · | 3.5% | 11.2% | 5.0% | · | 20.8% | 14.2% | 11.2% | · | 10.0% | 8.6% | 4.3% | · | 8.8% | |
| Net Margin | 6.7% | 4.4% | · | 0.85% | 6.3% | 1.9% | · | 15.5% | 9.0% | 6.3% | · | 5.2% | 4.3% | 0.62% | · | 16.8% | |
| Pretax Margin | 9.1% | 5.8% | · | 1.3% | 8.7% | 2.4% | · | 17.8% | 11.3% | 8.1% | · | 6.7% | 5.5% | 0.83% | · | 5.7% | |
| EBITDA Margin | 10.6% | 8.0% | · | 3.5% | 11.2% | 5.0% | · | 20.8% | 14.2% | 11.2% | · | 10.0% | 8.6% | 4.3% | · | 8.8% | |
| ROA | 1.0% | 0.60% | · | 0.12% | 0.93% | 0.26% | · | 2.1% | 1.3% | 0.85% | · | 0.69% | 0.62% | 0.09% | · | 2.3% | |
| ROE | 2.3% | 1.4% | · | 0.29% | 2.3% | 0.66% | · | 5.7% | 3.6% | 2.5% | · | 2.1% | 1.9% | 0.24% | · | 6.3% | |
| ROIC | 2.6% | 1.9% | · | 0.79% | 2.7% | 1.3% | · | 6.1% | 4.3% | 3.2% | · | 3.0% | 2.8% | 1.3% | · | 9.9% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 2.3 | · | 2.1 | 2.2 | 2.3 | · | 2.3 | 2.3 | 2.2 | · | 1.7 | 1.7 | 1.9 | · | 2.8 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.6 | 0.6 | 0.7 | · | 0.9 | |
| Interest Coverage | 4.6 | 3.6 | · | 1.6 | 4.9 | 1.9 | · | 7.1 | 4.9 | 3.6 | · | 3.0 | 2.7 | 1.2 | · | 2.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.5 | · | 1.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.27 | $32.51 | · | $32.21 | $32.04 | $31.24 | · | $29.81 | $28.17 | $27.31 | · | $25.44 | $24.93 | $24.04 | · | $22.89 | |
| Revenue / Share | $11.41 | $10.35 | · | $10.88 | $11.02 | $10.31 | · | $10.18 | $10.68 | $9.99 | · | $9.61 | $9.99 | $9.47 | · | $8.84 | |
| Cash Flow / Share | · | $0.44 | · | · | · | $1.33 | · | · | · | $0.93 | · | · | · | $-0.12 | · | · | |
| Dividend / Share | · | · | $0.00 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $1.85 | $1.77 | · | $2.06 | $3.54 | $3.81 | · | $4.21 | $3.14 | $2.61 | · | $2.01 | $2.99 | $-3.09 | · | $-2.95 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.37B | $1.37B | · | $1.35B | $1.33B | $1.32B | · | $1.29B | $1.28B | $1.26B | · | $1.17B | $1.14B | $1.10B | · | $1.07B | |
| Net Income TTM | $56M | $55M | · | $64M | $110M | $119M | · | $132M | $99M | $82M | · | $58M | $88M | $-94M | · | $-83M | |
| Market Cap | $1.02B | $1.11B | · | $1.47B | $1.63B | $1.89B | · | $2.25B | $2.17B | $2.51B | · | $3.16B | $4.25B | $3.25B | · | $2.51B | |
| P/E | 17.7 | 20.0 | · | 22.8 | 14.7 | 15.9 | · | 17.1 | 22.1 | 30.7 | · | 50.2 | 45.4 | -33.6 | · | -27.2 | |
| P/S | 0.7 | 0.8 | · | 1.1 | 1.2 | 1.4 | · | 1.7 | 1.7 | 2.0 | · | 2.7 | 3.7 | 3.0 | · | 2.3 | |
| P/B | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.9 | · | 2.4 | 2.5 | 2.9 | · | 4.0 | 5.5 | 4.3 | · | 3.5 | |
| P / Cash Flow | · | 82.2 | · | · | · | 45.5 | · | · | · | 86.1 | · | · | · | -845.0 | · | · | |
| Dividend Yield | 1.2% | 1.7% | · | 1.7% | 1.5% | 1.3% | · | 1.1% | 1.1% | 0.98% | · | 0.77% | 0.57% | 0.74% | · | 0.94% | |
| Earnings Yield | 5.7% | 5.0% | · | 4.4% | 6.8% | 6.3% | · | 5.9% | 4.5% | 3.3% | · | 2.0% | 2.2% | -3.0% | · | -3.7% | |
| Payout Ratio | · | 0.00% | · | · | · | 102.4% | · | · | · | 31.2% | · | · | · | 335.2% | · | · | |
| Annual Payout | $12M | $19M | · | $25M | $25M | $25M | · | $25M | $25M | $25M | · | $24M | $24M | $24M | · | $24M |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B |
| Bruttogewinnmarge % | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% |
| Betriebsgewinnmarge % | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% |
| Nettoergebnis | $47M | $132M | $64M | $-81M | $63M |
| Verwässerte EPS | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.1 | 2.3 | 2.0 | 2.0 | 2.3 |
| Quick Ratio | 0.8 | 0.9 | 0.8 | 0.6 | 0.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $151M | $154M | $106M | $12M | $97M |
Institutionelle Eigentümer (13F) 265 Einreicher · $1.3B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
265
Gehaltener Wert
$1.3B
Neue Positionen
42
Geschlossene Positionen
29
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (0 vs. Vorquartal) | 29 (-26 vs. Vorquartal) | 85 (-10 vs. Vorquartal) | 80 (+12 vs. Vorquartal) | +326K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $157.782.788 | 4.820.739 | 12,52% | Aktien |
| VANGUARD GROUP INC | $149.588.224 | 3.684.439 | 11,87% | Aktien |
| EARNEST PARTNERS LLC | $81.998.305 | 2.505.295 | 6,50% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $71.638.148 | 2.188.761 | 5,68% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $51.710.696 | 1.579.917 | 4,10% | Aktien |
| STATE STREET CORP | $46.393.728 | 1.417.468 | 3,68% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $44.372.977 | 1.355.728 | 3,52% | Aktien |
| BANK OF AMERICA CORP /DE/ | $43.904.317 | 1.341.409 | 3,48% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $43.121.568 | 1.317.370 | 3,42% | Aktien |
| SEI INVESTMENTS CO | $32.342.166 | 988.151 | 2,57% | Aktien |
| Invenomic Capital Management LP | $27.563.962 | 842.162 | 2,19% | Aktien |
| Capital Research Global Investors | $26.957.606 | 823.636 | 2,14% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $25.866.562 | 790.138 | 2,05% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $23.859.384 | 728.976 | 1,89% | Aktien |
| Allspring Global Investments Holdings, LLC | $20.260.323 | 618.447 | 1,61% | Aktien |
| COOKE & BIELER LP | $18.770.590 | 573.498 | 1,49% | Aktien |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $17.616.759 | 538.245 | 1,40% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $15.608.446 | 476.885 | 1,24% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15.416.550 | 471.022 | 1,22% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $14.445.802 | 441.361 | 1,15% | Aktien |
| GOLDMAN SACHS GROUP INC | $14.297.447 | 436.830 | 1,13% | Aktien |
| AMERIPRISE FINANCIAL INC | $14.279.731 | 436.289 | 1,13% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $12.132.684 | 370.690 | 0,96% | Aktien |
| NORTHERN TRUST CORP | $11.499.980 | 351.359 | 0,91% | Aktien |
| GLENMEDE TRUST CO NA | $10.594.733 | 323.701 | 0,84% | Aktien |
| Glenmede Investment Management, LP | $10.447.055 | 222.136 | 0,83% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $10.211.062 | 310.754 | 0,81% | Aktien |
| Bank of New York Mellon Corp | $9.531.081 | 291.203 | 0,76% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $9.194.380 | 280.916 | 0,73% | Aktien |
| Tributary Capital Management, LLC | $8.417.501 | 257.180 | 0,67% | Aktien |
| MORGAN STANLEY | $8.110.133 | 247.788 | 0,64% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $7.515.528 | 229.622 | 0,60% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $6.903.477 | 210.922 | 0,55% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $6.712.427 | 205.273 | 0,53% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.557.946 | 200.365 | 0,52% | Aktien |
| Trexquant Investment LP | $6.490.457 | 198.303 | 0,51% | Aktien |
| MARSHALL WACE, LLP | $5.742.610 | 175.454 | 0,46% | Aktien |
| Invesco Ltd. | $5.358.948 | 163.732 | 0,43% | Aktien |
| Legal & General Group Plc | $5.327.265 | 162.764 | 0,42% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $5.168.711 | 143.775 | 0,41% | Aktien |
| UBS Group AG | $4.669.098 | 142.655 | 0,37% | Aktien |
| CITADEL ADVISORS LLC | $4.656.268 | 142.263 | 0,37% | Aktien |
| TWO SIGMA ADVISERS, LP | $4.636.520 | 114.200 | 0,37% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $4.473.102 | 136.667 | 0,35% | Aktien |
| Dana Investment Advisors, Inc. | $4.314.763 | 131.829 | 0,34% | Aktien |
| ALGERT GLOBAL LLC | $4.297.220 | 131.293 | 0,34% | Aktien |
| JANE STREET GROUP, LLC | $4.074.099 | 124.476 | 0,32% | Aktien |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $4.045.927 | 114.421 | 0,32% | Aktien |
| WELLS FARGO & COMPANY/MN | $3.765.872 | 115.059 | 0,30% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.751.153 | 114.609 | 0,30% | Aktien |
Aktivisten & 5%+-Eigentümer 9 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Scopia Capital Management LP (2), Scopia Management, Inc. (2), Matthew Sirovich (2), Jeremy Mindich (2) ×5 Einreichungen | 22. August 2018 | · | Erste Einreichung | · | SEC |
| SCOPIA CAPITAL MANAGEMENT LP, SCOPIA MANAGEMENT, INC., MATTHEW SIROVICH, JEREMY MINDICH ×2 Einreichungen | 6. Mai 2016 | · | Erste Einreichung | · | SEC |
| SCOPIA PX LLC, SCOPIA PARTNERS LLC, SCOPIA HEALTH CARE LLC, SCOPIA WINDMILL FUND LP, SCOPIA INTERNATIONAL MASTER FUND LP, SCOPIA PX INTERNATIONAL MASTER FUND LP, SCOPIA HEALTH CARE INTERNATIONAL MASTER FUND LP, SCOPIA CAPITAL GP LLC, SCOPIA CAPITAL MANAGEMENT LP, SCOPIA MANAGEMENT, INC., MATTHEW SIROVICH, JEREMY MINDICH ×3 Einreichungen | 30. März 2016 | · | Erste Einreichung | · | SEC |
| COPPERSMITH CAPITAL MANAGEMENT, LLC, JEROME J. LANDE, CRAIG ROSENBLUM ×4 Einreichungen | 19. Februar 2016 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 16. Dezember 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 16. Juli 2004 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 29. Oktober 2003 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 6. Mai 2003 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 23. Januar 2003 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 60 Insider · 38 Führungskräfte · 21 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Pat Beyer | President & CEO | 1. April 2026 A | 10.807 | 0 | 0 | $0 |
| Curt R Hartman | President and CEO | 7. November 2024 M | 9.996 | 0 | 0 | $0 |
| Joseph J Corasanti | Former President & CEO | 30. Juli 2014 M | 156.356 | 0 | 0 | $0 |
| John E Gallagher | Executive Vice President & CFO | 15. Juli 2026 A | · | 0 | 0 | $0 |
| Todd W. Garner | Executive Vice President & CFO | 6. November 2025 S | 1.836 | 0 | 1 | $-150.500 |
| Robert D Shallish JR | EVP, Finance, CFO | 31. Dezember 2014 A | 53.876 | 0 | 0 | $0 |
| Stanley W Peters III | President AS and AET | 14. Juni 2024 M | 63 | 0 | 0 | $0 |
| Gerald G Woodard | PRESIDENT LINVATEC | 30. Mai 2007 M | 0 | 0 | 0 | $0 |
| David R Murray | President Electrosurgery | 17. Mai 2007 A | 269 | 0 | 0 | $0 |
| Eugene Starr | President-Electrosurgery | 5. Januar 2004 A | 787 | 0 | 0 | $0 |
| Matthew Schabacker | VP GM Advanced Surgical | 2. März 2026 A | · | 0 | 0 | $0 |
| Andrew James Moller | VP Corporate Controller | 2. März 2026 A | · | 0 | 0 | $0 |
| Hollie K Foust | General Counsel & Corp Sec | 2. März 2026 A | 2.886 | 0 | 0 | $0 |
| John D. Ferrell | Executive Vice President - HR | 2. März 2026 A | 702 | 0 | 0 | $0 |
| Brent Lalomia | Executive VP RA, QA | 2. März 2026 A | 915 | 0 | 0 | $0 |
| Johonna Marie Pelletier | Treasurer and VP, Tax | 2. März 2026 A | 1.317 | 0 | 0 | $0 |
| Peter K Shagory | EVP, STRAT & CORP DEVT | 2. März 2026 A | 3.897 | 0 | 0 | $0 |
| Richard Glaze | Chief Information Officer | 21. November 2025 S | 0 | 0 | 1 | $-10.591 |
| Edward A. Clifford | VP Global Manufacturing | 3. März 2025 A | 378 | 0 | 0 | $0 |
| Stephan Epinette | VP GM International | 3. März 2025 A | · | 0 | 0 | $0 |
| Heather L Cohen | EVP & Chief HR & Legal Officer | 28. März 2024 A | 35.992 | 0 | 0 | $0 |
| Terence M Berge | VP-Corporate Controller | 1. März 2024 A | 1.004 | 0 | 0 | $0 |
| Daniel S Jonas | Special Counsel & Corp Secy | 28. April 2023 M | 13.462 | 0 | 0 | $0 |
| Jaclyn Peterson | VP of Mfg. & Adv. Engineering | 1. März 2023 M | 739 | 0 | 0 | $0 |
| John Jed Kennedy | Group Executive Vice President | 3. März 2022 M | 9.855 | 0 | 0 | $0 |
| Wilfredo Ruiz-Caban | EVP QA, RA and Operations | 30. Juni 2020 A | 3.975 | 0 | 0 | $0 |
| Nathan Folkert | VP GM Orthopedics | 2. März 2020 A | 2.280 | 0 | 0 | $0 |
| Mark D Snyder | EVP Mfg. Ops & Business System | 31. März 2016 D | 20.130 | 0 | 0 | $0 |
| Gregory Renard Jones | EVP-Corporate QA/RA | 30. September 2015 A | 15.465 | 0 | 0 | $0 |
| Joseph G Darling | EVP, Commercial Operations | 2. Februar 2015 M | 16.837 | 0 | 0 | $0 |
| William Abraham | EVP-Business Development | 30. September 2014 M | 4.872 | 0 | 0 | $0 |
| David Allen Johnson | VP - Global Operations | 25. Februar 2010 M | 468 | 0 | 0 | $0 |
| Jane E Metcalf | VP CORPORATE REG. AFFAIRS | 1. Juni 2008 A | 1.634 | 0 | 0 | $0 |
| Alexander Jones | VP/Corporate Sales | 29. Juni 2007 A | 5.451 | 0 | 0 | $0 |
| Thomas Acey | SECRETARY & TREASURER | 13. Juni 2007 A | 3.475 | 0 | 0 | $0 |
| Frank R Williams | VICE PRESIDENT | 5. Juni 2007 M | 4.926 | 0 | 0 | $0 |
| Dennis M Werger | Gen. Man. of CONMED Endo Tech | 17. Mai 2007 A | 269 | 0 | 0 | $0 |
| John J Stotts | VICE PRESIDENT | 17. Mai 2007 A | 45.275 | 0 | 0 | $0 |
| Kim Kelderman | Direktor | 8. September 2026 M | 500 | 0 | 0 | $0 |
| Celine Christine Martin | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Jeffrey B. Mirviss | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Laverne H Council | Direktor | 2. Juni 2026 M | 4.716 | 0 | 0 | $0 |
| Barbara J Schwarzentraub | Direktor | 2. Juni 2026 M | 5.012 | 0 | 0 | $0 |
| Mark Kaye | Direktor | 2. Juni 2026 M | 820 | 0 | 0 | $0 |
| Charles Farkas | Direktor | 2. Juni 2026 M | 15.527 | 0 | 0 | $0 |
| David M Bronson | Direktor | 2. Juni 2026 M | 17.909 | 0 | 0 | $0 |
| Martha Goldberg Aronson | Direktor | 3. Juni 2025 M | 12.391 | 0 | 0 | $0 |
| Brian Concannon | Direktor | 3. Juni 2025 M | 10.116 | 0 | 0 | $0 |
| John L Workman | Direktor | 20. Mai 2025 M | 20.891 | 0 | 0 | $0 |
| Jerome J. Lande | Direktor | 31. Mai 2024 M | 3.856 | 0 | 0 | $0 |
| Mark E Tryniski | Direktor | 1. Juni 2022 M | 9.108 | 0 | 0 | $0 |
| Dirk Kuyper | Direktor | 2. August 2019 M | 5.000 | 0 | 0 | $0 |
| Jo Ann Golden | Direktor | 1. Juni 2018 M | 9.949 | 0 | 0 | $0 |
| Bruce Daniels | Direktor | 30. Juli 2014 S | 5.000 | 0 | 0 | $0 |
| Eugene R Corasanti | Direktor | 23. Juli 2014 M | 84.558 | 0 | 0 | $0 |
| Stuart J Schwartz | Direktor | 1. Juni 2014 M | 10.600 | 0 | 0 | $0 |
| William Matthews | Direktor | 18. Mai 2007 A | 5.500 | 0 | 0 | $0 |
| Robert Remmell | Direktor | 19. Mai 2004 A | 675 | 0 | 0 | $0 |
| Luke A Pomilio | · | 1. März 2018 M | 0 | 0 | 0 | $0 |
| Stephen Mandia | · | 29. Mai 2015 S | 1 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 51 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,58% | 23.645 NS | 31. Juli 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,87% | 36.511 NS | 31. Juli 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 0,81% | 838 NS | 31. Juli 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,75% | 28.525 SH | 5. Oktober 2026 | Täglich |
| HAPS · Harbor ETF Trust | 0,72% | 26.439 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,45% | 133.262 NS | 31. Juli 2026 | N-PORT |
| IHI · iShares Trust | 0,21% | 143.754 SH | 11. September 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,18% | 2.398 NS | 31. Juli 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,17% | 6.314 NS | 31. Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,17% | 1.295 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 71.113 SH | 5. Oktober 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 14.734 NS | 31. Juli 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,11% | 63.889 SH | 19. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,09% | 4.827 SH | 5. Oktober 2026 | Täglich |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,09% | 37.291 SH | 5. Oktober 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 20.212 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,07% | 124.576 NS | 31. Juli 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,07% | 178 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 26.474 SH | 19. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 7.846 NS | 31. Juli 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 104.975 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,05% | 791.772 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,05% | 14.710 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 177.248 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 69.686 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 14.669 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 437.495 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 1.673 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 42.499 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1.911 SH | 10. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 347.035 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,01% | 688.644 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 90.678 SH | 19. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 2.844 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 15.120 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43.369 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 8.067 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 18.466 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 4.730 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 958.140 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 20.172 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.626 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,00% | 6.847 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 1.836.934 SH | 10. September 2026 | Täglich |
| IJS · iShares Trust | · | 268.002 SH | 8. September 2026 | Täglich |
| IWN · iShares Trust | · | 289.600 SH | 11. September 2026 | Täglich |
| XJR · iShares Trust | · | 4.179 SH | 31. August 2026 | Täglich |
| SVAL · iShares Trust | · | 16.593 SH | 3. September 2026 | Täglich |
| ISCB · iShares Trust | · | 1.278 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 6.330 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 33.440 SH | 11. September 2026 | Täglich |
CNMD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 12 Analysten
HALTEN
Median-Ziel
$45.00
+1,2%
0 0,0%
Starker Kauf
0 0,0%
Kauf
8 66,7%
Halten
2 16,7%
Verkauf
2 16,7%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $45.50 +2,3%
Jetzt
Aktueller Preis $44.48
Tief$43.00
Mittelwert$45.50
Hoch$49.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| LMAT | $1.85B | 32.2 | 13.5% | 23.1% | 15.3% | 71.5% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| OMCL | $2.04B | 1132.5 | 6.5% | 0.17% | 0.16% | 42.5% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| TNDM | $1.50B | -7.2 | 7.9% | -20.2% | -141.9% | 53.8% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 29, 2026